Logo image
Back
RAB19, SERPINB9P1, and Pancreatitis in Patients Taking Azathioprine in Routine Clinical Practice: Genome and Transcriptome-Wide Association Studies
Journal article   Open access   Peer reviewed

RAB19, SERPINB9P1, and Pancreatitis in Patients Taking Azathioprine in Routine Clinical Practice: Genome and Transcriptome-Wide Association Studies

Shailja C Shah, Tyler S Reese, Laura L Daniel, Jacy Zanussi, Alyson L Dickson, Puran Nepal, Ran Tao, Tyne Miller-Fleming, Peter Straub, Jennifer Maizel, …
Clinical pharmacology and therapeutics, Vol.118(4), pp.946-953
2025
DOI: https://doi.org/10.1002/cpt.70003
PMID: 40698913
pdf
Published730.66 kBDownloadView
Open Access CC BY-NC-ND V4.0

Abstract

Adult Aged Azathioprine - adverse effects Female Genome-Wide Association Study Humans Immunosuppressive Agents - adverse effects Male Middle Aged Pancreatitis - chemically induced Pancreatitis - genetics Polymorphism, Single Nucleotide rab GTP-Binding Proteins - genetics Retrospective Studies Transcriptome
Azathioprine is used to treat several inflammatory and autoimmune diseases. However, its use is limited by serious adverse events, including acute pancreatitis. Prior studies have found an association between the HLA region and thiopurine-induced acute pancreatitis (TIAP); however, in clinical practice, many patients with pancreatitis do not meet this strict criterion. We aimed to identify additional genes associated with azathioprine-related pancreatitis using genome-wide and transcriptome-wide association studies (GWAS and TWAS) by broadening the definition of pancreatitis. We conducted a retrospective study of azathioprine users with inflammatory conditions. We used electronic health records linked to genomic data from BioVU (Vanderbilt's biobank) and replicated the results using NIH's All of Us. The primary outcome was acute pancreatitis, and the secondary outcome was pancreatic injury. Sixteen patients with pancreatitis and 2085 control subjects were included from BioVU; the All of Us cohort included < 20 patients with pancreatitis and 847 control subjects. The GWAS analysis (adjusted for 10 principal components of genetic ancestry, sex, age, and azathioprine indication) in the BioVU cohort found an association between pancreatic injury and rs2948386 in RAB19 (OR = 3.47, P = 1.46E−8), which was replicated in All of Us (OR = 2.70, P = 4.18E−3). We also conducted a TWAS adjusting for the same factors above and found a significant association between genetically predicted pancreatic expression of SERPINB9P1 with pancreatic injury (BioVU: effect size = 0.42, P = 1.48E-5; All of Us: effect size = 0.48, P-value = 0.01). In summary, we identified two new genetic associations for azathioprine-related pancreatic injury: the predicted expression of SERPINB9P1 and a SNP in RAB19.

Details

UN Sustainable Development Goals (SDGs)

This output has contributed to the advancement of the following goals:

#3 Good Health and Well-Being

Source: SDGs in the Output

Metrics

1 Record Views
Logo image